Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Glycolysis Restoration Attenuates Damaged Bone Marrow Endothelial Cells

Zhong-Shi Lyu, PhD, Wei-Li Yao, Qi Wen, MD, Hong-Yan Zhao, MD, Fei-Fei Tang, Yu Wang, Lan-Ping Xu, Xiao-Hui Zhang, Hsiang-Ying Lee, PhD, Xiao-Jun Huang, Yuan Kong, MD PhD

Blood (2019) 134 (Supplement_1): 2491.

https://doi.org/10.1182/blood-2019-122794

Published: 2019

Journal Articles

Regulation of the Elevated T Cell Glycolysis May Alleviate Acute Graft-Versus-Host Disease Post-Allotransplant

Qi Wen, MD, Song Yang, Zhong-Shi Lyu, PhD, Wei-Li Yao, Yu-Hong Chen, Ting-Ting Han, Yu Wang, Lan-Ping Xu, Xiao-Hui Zhang, Xiao-Jun Huang, Yuan Kong, MD PhD

Blood (2019) 134 (Supplement_1): 600.

https://doi.org/10.1182/blood-2019-122795

Published: 2019

Journal Articles

Autophagy in Endothelial Cells Regulates Their Hematopoiesis Supporting Ability

Yuan Kong, MD PhD, Xie-Na Cao, Zhong-Shi Lyu, PhD, Xiao-Dong Mo, Qi Wen, MD, Hong-Yan Zhao, MD, Yu-Hong Chen, Yu Wang, Ying-Jun Chang, Lan-Ping Xu, Xiao-Hui Zhang, Xiao-Jun Huang

Blood (2019) 134 (Supplement_1): 4425.

https://doi.org/10.1182/blood-2019-122227

Published: 2019

Journal Articles

Prophylactic Intervention with N-Acetyl-L-Cysteine before Allotransplant Could Reduce the Occurrence of Poor Hematopoietic Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation

Yuan Kong, MD PhD, Yu Wang, Yuan-Yuan Zhang, Min-Min Shi, Xiao-Dong Mo, Yu-Qian Sun, MD, Ying-Jun Chang, Lan-Ping Xu, Xiaohui Zhang, MD, Kaiyan Liu, MD PhD, Xiao-Jun Huang

Blood (2018) 132 (Supplement 1): 2074.

https://doi.org/10.1182/blood-2018-99-111652

Published: 2018

Journal Articles

Janus Kinase Inhibition By Ruxolitinib Combined with Nilotinib Has Superior Anti-Leukemia Propagating Cells Effect in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Yuan Kong, MD PhD, Yi-Lin Wu, Yang Song, Min-Min Shi, Ya-Zhen Qin, Yue-Yun Lai, Hao Jiang, MD, Qian Jiang, Xiao-Jun Huang

Blood (2016) 128 (22): 4023.

https://doi.org/10.1182/blood.V128.22.4023.4023

Published: 2016

Journal Articles

Dysfunction of Bone Marrow Endothelial Progenitor Cells from Subjects with Poor Graft Function Following Allogeneic Hematopoietic Stem Cell Transplantation Can be Improved By Atorvastatin

Minmin Shi, Yuan Kong, MD PhD, Yang Song, Yuqian Sun, Yu Wang, Xiaohui Zhang, Lanping Xu, Kaiyan Liu, Xiaojun Huang

Blood (2016) 128 (22): 3386.

https://doi.org/10.1182/blood.V128.22.3386.3386

Published: 2016

Journal Articles

Abnormalities of Bone Marrow Immune Micro-Environment in Patients with Immune Thrombocytopenia

Yang Song, Yu-tong Wang, Xiao-jun Huang, Yuan Kong, MD PhD

Blood (2015) 126 (23): 3464.

https://doi.org/10.1182/blood.V126.23.3464.3464

Published: 2015

Journal Articles

Dysregulated T Cell Response in Bone Marrow Immune Micro-Environment of Patients with Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation

Yu-tong Wang, Yuan Kong, MD PhD, Yang Song, Zheng-Fan Jiang, Xiao-jun Huang

Blood (2015) 126 (23): 3140.

https://doi.org/10.1182/blood.V126.23.3140.3140

Published: 2015

Journal Articles

Increased Levels of Reactive Oxygen Species and Exhaustion of the Quiescent CD34 + Cells May Operate in Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation

Yuan Kong, MD PhD, Yue Hu, Yang Song, Yu-Tong Wang, Zheng-Fan Jiang, Hong-Kui Deng, Xiao Jun Huang

Blood (2015) 126 (23): 4337.

https://doi.org/10.1182/blood.V126.23.4337.4337

Published: 2015

Journal Articles

CD34 + CD38 - CD58 - Candidate Leukemia-Initiating Cells Are Clinically Relevant With The Unfavorable Prognosis In Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Yuan kong, MD, PhD, Ying-Jun Chang, PhD, Yan-rong Liu, MD, Ya-zhe Wang, Qian Jiang, Hao Jiang, Ya-Zhen Qin, MS, Jing Wang, Hong-Hu Zhu, MD, Yue-Yun Lai, Lanping Xu, Dai-Hong Liu, MD, PhD, Xiao-Jun Huang, MD, PhD

Blood (2013) 122 (21): 354.

https://doi.org/10.1182/blood.V122.21.354.354

Published: 2013

Journal Articles

CD58-Negtive Leukemia Initiating Cells Are Independently Associated with High Risk of Relapse in B-Precursor Acute Lymphoblastic Leukemia: A Comprehensive Clinical and Biological Profiling Study

Yuan Kong, MD, PhD, Yanrong Liu, MD, Honghu Zhu, PhD, Qian Jiang, MD, Hao Jiang, MD, Lan-Ping Xu, MD, Dai-Hong Liu, MD, PhD, Guo-Rui Ruan, PhD, Bin Jiang, MD, Kaiyan Liu, MD, Xiao-jun Huang, MD, PhD

Blood (2012) 120 (21): 1397.

https://doi.org/10.1182/blood.V120.21.1397.1397

Published: 2012

Journal Articles

Leukemia Initiating Cells: New Markers for Minimal Residual Disease Monitoring in B-Precursor Acute Lymphoblastic Leukemia

Yuan Kong, MD, PhD, Yan-rong Liu, MD, Le Hao, Ya-zhe Wang, Kai-yan Liu, MD, PhD, Xiao-jun Huang, MD, PhD

Blood (2011) 118 (21): 2528.

https://doi.org/10.1182/blood.V118.21.2528.2528

Published: 2011

Journal Articles

Antitumor Activity and Mechanism of Action of a Novel Stat3 Inhibitor, WP1066, Against Human B-Cell Non-Hodgkin’s Lymphoma and Multiple Myeloma.

Ling-Yuan Kong, MD, PhD, Vaibhav Kapuria, Geoffrey Bartholomeusz, PhD, Moshe Talpaz, MD, Waldemar Priebe, PhD, Nicholas J. Donato, PhD

Blood (2005) 106 (11): 1489.

https://doi.org/10.1182/blood.V106.11.1489.1489

Published: 2005

Journal Articles

Constitutive Activation of SRC-Family Kinases in Chronic Myelogenous Leukemia Patients Resistant to Imatinib Mesylate in the Absence of BCR-ABL Mutations: A Rationale for Use of SRC/ABL Dual Kinase Inhibitor-Based Therapy.

Nicholas J. Donato, PhD, Ji Wu, MD, Ling-Yuan Kong, MD, PhD, Feng Meng, MD, Francis Lee, PhD, Moshe Talpaz, MD

Blood (2005) 106 (11): 1087.

https://doi.org/10.1182/blood.V106.11.1087.1087

Published: 2005

Journal Articles

Human CB-Derived Cells Give Rise to Insulin-Producing-Cells in Xenogeneic Hosts.

Shuro Yoshida, MD, Fumihiko Ishikawa, MD, PhD, Noriaki Kawano, MD, Hua Zhang, MD, Yuan Kong, MD, Kazuya Shimoda, MD, Leonard D. Shultz, PhD, Mine Harada, MD

Blood (2004) 104 (11): 3603.

https://doi.org/10.1182/blood.V104.11.3603.3603

Published: 2004

NARROW

Glycolysis Restoration Attenuates Damaged Bone Marrow Endothelial Cells

Regulation of the Elevated T Cell Glycolysis May Alleviate Acute Graft-Versus-Host Disease Post-Allotransplant

Autophagy in Endothelial Cells Regulates Their Hematopoiesis Supporting Ability

Prophylactic Intervention with N-Acetyl-L-Cysteine before Allotransplant Could Reduce the Occurrence of Poor Hematopoietic Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation

Janus Kinase Inhibition By Ruxolitinib Combined with Nilotinib Has Superior Anti-Leukemia Propagating Cells Effect in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Dysfunction of Bone Marrow Endothelial Progenitor Cells from Subjects with Poor Graft Function Following Allogeneic Hematopoietic Stem Cell Transplantation Can be Improved By Atorvastatin

Abnormalities of Bone Marrow Immune Micro-Environment in Patients with Immune Thrombocytopenia

Dysregulated T Cell Response in Bone Marrow Immune Micro-Environment of Patients with Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation

Increased Levels of Reactive Oxygen Species and Exhaustion of the Quiescent CD34 + Cells May Operate in Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation

CD34 + CD38 - CD58 - Candidate Leukemia-Initiating Cells Are Clinically Relevant With The Unfavorable Prognosis In Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

CD58-Negtive Leukemia Initiating Cells Are Independently Associated with High Risk of Relapse in B-Precursor Acute Lymphoblastic Leukemia: A Comprehensive Clinical and Biological Profiling Study

Leukemia Initiating Cells: New Markers for Minimal Residual Disease Monitoring in B-Precursor Acute Lymphoblastic Leukemia

Antitumor Activity and Mechanism of Action of a Novel Stat3 Inhibitor, WP1066, Against Human B-Cell Non-Hodgkin’s Lymphoma and Multiple Myeloma.

Constitutive Activation of SRC-Family Kinases in Chronic Myelogenous Leukemia Patients Resistant to Imatinib Mesylate in the Absence of BCR-ABL Mutations: A Rationale for Use of SRC/ABL Dual Kinase Inhibitor-Based Therapy.

Human CB-Derived Cells Give Rise to Insulin-Producing-Cells in Xenogeneic Hosts.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only